首页> 外文期刊>Iranian Journal Of Allergy, Asthma and Immunology >Adenovirus-mediated Gene Therapy for Allergy
【24h】

Adenovirus-mediated Gene Therapy for Allergy

机译:腺病毒介导的过敏基因治疗

获取原文
       

摘要

Allergy poses a heavy health burden in modern society. Other than symptom-relieving medications, the only available treatment approach is allergen-specific immunotherapy, which in spite of offering a potential cure, requires a long treatment duration with multiple doses of allergen administration and carries a risk of anaphylaxis. Gene therapy has shown advantages in experimental studies for treatment of tumors, genetic diseases, chronic infections, and allergy. To date, adenovirus has been the most extensively used gene transfer vector, and offers high efficiency and safety. Here, we review studies of adenovirus-mediated gene therapy targeting different steps in the development of allergic diseases. Adenovirus-mediated gene therapy might be a promising add-on therapy for allergy treatment.
机译:过敏在现代社会中构成沉重的健康负担。除缓解症状的药物外,唯一可用的治疗方法是过敏原特异性免疫疗法,尽管提供了潜在的治愈方法,但仍需要较长剂量的多次过敏原治疗才能持续治疗,并且存在过敏反应的风险。基因疗法在治疗肿瘤,遗传疾病,慢性感染和过敏的实验研究中已显示出优势。迄今为止,腺病毒已成为使用最广泛的基因转移载体,并具有高效和安全性。在这里,我们回顾了针对变应性疾病发展中不同步骤的腺病毒介导的基因治疗的研究。腺病毒介导的基因治疗可能是变态反应治疗的有前途的附加治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号